IONS (Isis Pharmaceuticals) Tambahing bathi saben saham ing taun lumaku
The financial stability of Ionis Pharmaceuticals (IONS) is supported by a significant liquidity reserve and the management of clinical phase risks. The annual EPS growth trajectory confirms the effectiveness of this strategy, and the value of -45.70 shows the most recent earnings per share. Revenues are based on research contracts and royalties, while strategic alliances with pharma behemoths accelerate the market launch of therapies for rare pathologies.
Rincian metrik keuangan lan pasar Ionis Pharmaceuticals (IONS)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- rincian valuasi buku bisnis:
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Ionis Pharmaceuticals|IONS - Utang jangka dawa marang modal|Utang jangka cendhak marang modal ionispharma.com|IONS - Gunggung utang perusahaan|Utang marang nilai buku Isis Pharmaceuticals|IONS - Utang jangka dawa perusahaan|Utang jangka cendhak Ionis|Rasio cepet ionispharma.com
- rincian bathi lan kelipatan pasar:
IONS - Penghasilan resik|Bathi resik mangsa ngarep Ionis Pharmaceuticals|IONS - Pangali P/E|Kapitalisasi marang proyeksi bathi Isis Pharmaceuticals|IONS - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Isis Pharmaceuticals|IONS - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Ionis|IONS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ionispharma.com|IONS - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Ionis Pharmaceuticals
- data pendapatan lan penerimaan dodolan:
Pambiji fundamental:IONS, Ionis Pharmaceuticals, Inc.
To objectively evaluate Ionis Pharmaceuticals (IONS), it is critical to filter out market noise and analyze real yield dynamics. By analyzing the annual volatility of earnings per share, an investor can see the percentage ratio of current EPS to the previous year, revealing true capital stability beyond speculation. For a developer of RNA therapeutics with a low environmental footprint, such a metric confirms the efficiency of capitalizing pure laboratory research into real financial growth.
Pesaing langsung
Dinamika bathi saben saham ing taun lumaku TEM (Tempus Labs)|QGEN (Qiagen Group) - Wutah bathi ing taun lumaku|RGEN: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku RNA|Wutah bathi ing taun lumaku crisprtx.com (CRSP)|Wutah bathi saben saham ing taun lumaku GeneDx WGS|Tambahing bathi saben saham ing taun lumaku RARE|BEAM - Wutah bathi saben saham ing taun lumaku|Sarepta Corp (SRPT) - Wutah bathi resik saben saham ing taun iki|TWST: Wutah bathi ing taun lumaku|10xgenomics.com (TXG) - Wutah bathi ing taun lumaku|NTLA (Intellia Therapeutics, Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Stoke Therapeutics Inc (STOK)|Wutah bathi ing taun lumaku BLFS|WVE - Kacepetan wutah bathi saben saham ing taun lumaku|Maze Therapeutics Inc - Wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku sionnatx.com SION|PRME: Wutah bathi resik saben saham ing taun iki|Taysha Gene Therapies Inc - Wutah bathi resik saben siji saham kanggo taun lumaku|QURE: Wutah bathi ing taun lumaku|MGTX - Prakiraan wutah bathi resik saben saham ing taun iki|RGNX (REGENXBIO Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki solidbio.com (SLDB)|Wutah bathi ing taun lumaku OCGN|Wutah bathi ing taun lumaku Pacific Biosciences of California, Inc. (PACB)|Wutah bathi saben saham ing taun lumaku Benitec BNTC|Design Corp - Wutah bathi saben saham ing taun lumaku|RCKT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki 4dmoleculartherapeutics.com FDMT|LXEO: Wutah bathi ing taun lumaku|KRRO - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Editas|Kacepetan wutah bathi saben saham ing taun lumaku Silence Therapeutics Corp SLN|Wutah bathi saben saham ing taun lumaku ProQR Therapeutics N.V. (PRQR)|codexis.com - Wutah bathi saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Sangamo Therapeutics, Inc. SGMO|Prakiraan wutah bathi resik saben saham ing taun iki Nautilus Biotechnology, Inc. (NAUT)|Metagenomi, Inc - Wutah bathi ing taun lumaku|DTIL (precisionbiosciences.com) - Wutah bathi saben saham ing taun iki|generationbio.com (GBIO) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki BOLD|XCUR (Exicure Inc.) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Celsion Corporation|Wutah bathi ing taun lumaku PHIO|Prakiraan wutah bathi resik saben saham ing taun iki mustangbio.com|Wutah bathi saben saham ing taun lumaku TransCode Therapeutics, Inc. RNAZ|Bionano Genomics Inc. (BNGO) - Kacepetan wutah bathi saben saham ing taun lumaku|APDN - Wutah bathi saben saham ing taun lumaku|BLUE (bluebird bio Inc.) - Wutah bathi saben saham ing taun iki|IPA: Wutah bathi ing taun lumaku|OMGA - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Singular Genomics Systems|regulusrx.com (RGLS) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki SYRS (Syros Pharmaceuticals, Inc.)|TBIO (Telesis Bio Inc.) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku TRACON TCON|UBX (Unity Biotechnology, Inc) - Dinamika bathi saben saham ing taun lumaku
